Search

Search Constraints

You searched for: Author/Creator Shirono, Tomotake

Search Results

1. Cover Image, Volume 43, Issue 4. Issue 4 (12th April 2023)

2. Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma. Issue 8 (August 2016)

3. Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma. Issue 9 (3rd June 2022)

4. Effects of in‐hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver disease. Issue 3 (5th May 2016)

5. Effects of in‐hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. Issue 3 (16th December 2018)

6. Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound. Issue 2 (9th June 2021)

7. First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study. (24th October 2021)

8. Global multi-stakeholder endorsement of the MAFLD definition. (May 2022)

9. Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study. Issue 12 (21st October 2021)

10. Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis. Issue 8 (20th June 2020)